The FDA is considering a Wegovy shortage
More than 200,000 prescriptions for copies of Novo Nordisk’s weight-loss drug Wegovy are purchased by patients in the US each month, an industry group said in a letter to the US drug regulator, saying it should consider their role in alleviating supply shortages of obesity drugs before banning them.
BELIEBTE BEITRÄGE
North Carolina city sues Duke Energy over climate crisis
Dezember 6, 2024
Earthquake of magnitude 5.7 strikes western Iran
Dezember 6, 2024
Soy traders push to soften ban on buying Amazon produce
Dezember 6, 2024
Tom Tykwer’s ‘The Light’ will open the 2025 Berlin Film Festival
Dezember 6, 2024
LIVEÜBERTRAGUNG